LYKALABS Stock Today

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>LL</div>
LYKA LABORATORIES is trading at 15.75 as of the 29th of May 2020, which is 1.29 percent up since the beginning of the trading day. The stock's open price was 15.55. LYKA LABORATORIES has 49 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 30 days. Equity ratings for LYKA LABORATORIES are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 29th of February 2020 and ending today, the 29th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance0 100 


Lyka Labs Limited engages in manufacturing pharmaceutical formulations and active pharmaceutical ingredients various therapeutic segments in India. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India. LYKA LABORATORIES operates under Biotechnology classification in India and is traded on National Stock Exchange of India. more on LYKA LABORATORIES
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of LYKA LABORATORIES available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Strong SellOver Valued
LYKA LABORATORIES (LYKALABS) is traded on National Stock Exchange of India in India and employs 4 people. The company currently falls under 'Small-Cap' category with current market capitalization of 520.62 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LYKA LABORATORIES's market, we take the total number of it shares issued and multiply it by the LYKA LABORATORIES's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. LYKA LABORATORIES operates under Healthcare sector and is part of Biotechnology industry. The entity has 28.69 M outstanding shares. LYKA LABS LTD has accumulated about 74.5 M in cash with 728.33 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.62.
Check LYKA LABORATORIES Probability Of Bankruptcy

LYKALABS Stock Price Odds Analysis

Odds Down 15.75HorizonTargetOdds Up 15.75
35.89%30 days
Based on normal probability distribution, the odds of LYKA LABORATORIES to move above current price in 30 days from now is about 64.01 (This LYKA LABORATORIES probability density function shows the probability of LYKA LABORATORIES Stock to fall within a particular range of prices over 30 days) .


LYKALABS Stock Against Markets

Did you try this?

Run Competition Analyzer Now


Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module
Additionally, see Stocks Correlation. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page